| Literature DB >> 31779259 |
Kenichiro Yaita1, Kenji Gotoh2, Ryuichi Nakano3, Jun Iwahashi2, Yoshiro Sakai4, Rie Horita5, Hisakazu Yano3, Hiroshi Watanabe2.
Abstract
Bloodstream infection (BSI) due to carbapenem-resistant Enterobacteriaceae (CRE) has a high mortality rate and is a serious threat worldwide. Ten CRE strains (eight Enterobacter cloacae, one Klebsiella pneumoniae and one Citrobacter freundii) were isolated from the blood of nine patients, a percentage of whom had been treated with indwelling devices. The steps taken to establish cause included minimum inhibitory concentration (MIC) tests, a pulsed-field gel electrophoresis (PFGE), biofilm study, a multiplex PCR for resistant genes of carbapenemases and extended-spectrum beta-lactamases (ESBLs), and plasmid incompatibility typing. All strains showed a tendency toward resistance to multiple antibiotics, including carbapenems. Frequently isolated genes of ESBLs and carbapenemases include blaTEM-1 (four strains), blaSHV-12 (four strains) and blaIMP-1 (six strains). A molecular analysis by PFGE was used to divide the XbaI-digested genomic DNAs of 10 CRE strains into eight patterns, and the analysis showed that three E. cloacae strains detected from two patients were either identical or closely related. The biofilm production of all CRE strains was examined using a microtiter biofilm assay, and biofilm growth in continuous flow chambers was observed via the use of a confocal laser scanning microscope. Our study indicates that biofilm formation on indwelling devices may pose a risk of BSI due to CRE.Entities:
Keywords: CRE; biofilm; bloodstream infection; carbapenem-resistant Enterobacteriaceae
Mesh:
Substances:
Year: 2019 PMID: 31779259 PMCID: PMC6928744 DOI: 10.3390/ijms20235954
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Patient characteristics.
| Case No. | The Month of Detection CRE | Age, Sex | Primary Infection | Underlying Disease | Indwelling Devices | Antibiotic Therapy | Outcome |
|---|---|---|---|---|---|---|---|
| 1 | 2014.11 | 40, Male | Acute pyelonephritis | Chronic kidney disease, Hemodialysis | Urinary tract stent | Meropenem+Ciprofloxacin | Survive |
| 2 | 2015.2 | 62, Male | Febrile neutroenia | Diffuse large B-cell lymphoma, Bone marrow transplantation | Central venous catheter | Meropenem | Death |
| 3 | 2015.2 | 21, Female | Catheter-related blood stream infection | Mixed connective tissue disease, Acute kidney injury, Hemodialysis | Central venous catheter, Urethral catheter | Piperacillin/tazobactam+Tigecycline | Death |
| 4 | 2015.7 | 71, Male | Acute pyelonephritis | Renal cell carcinoma | Urinary tract stent, Urethral catheter | Tigecycline+Amikacin | Survive |
| 5 | 2015.8 | 79, Female | Obstructive cholangitis | Papilla cancer, Diabetes mellitus | Retrograde transhepatic biliary drainage tube | Levofloxacin | Survive |
| 6 | 2015.8 | 56, Male | Acute pyelonephritis | Urinary tract stone, Diabetes mellitus | Urinary tract stent, Urethral catheter | Meropenem | Survive |
| 7 | 2015.9 | 59, Female | Vertebral osteomyelitis | Diffuse large B-cell lymphoma, Lung cancer | Central venous catheter | Tigecycline+Amikacin | Survive |
| 8 | 2015.11 | 84, Male | Acute pyelonephritis | Benign prostatic hyperplasia | None | Cefepime | Survive |
| 9 | 2015.12 | 31, Male | Primary bacteremia | Severe burn, acute respiratory distress syndrome, Diabetes mellitus | Central venous catheter, Urethral catheter | Levofloxacin | Survive |
Minimum inhibitory concentrations, resistant genes, and transmission frequencies of our strains.
| Case No. | Species | CFPM | CMZ | IPM | MEPM | P/T | AMK | LVFX | Resistant Genes | Transfer Frequency |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
| >16 | >32 | 2 | >2 | 64 | <4 | <0.5 |
| not transferred |
| 2 |
| 16 | >32 | <1 | 2 | 64 | <4 | 2 |
| not transferred |
| 3 |
| 16 | >32 | <1 | >2 | <16 | <4 | >4 |
| 4.0 × 10−7 |
| 4 |
| >16 | >32 | 2 | 2 | >64 | 16 | >4 |
| not determined |
| 5 |
| <2 | >32 | 2 | >2 | <16 | <4 | <0.5 |
| 1.8 × 10−6 |
| 6 |
| >16 | >32 | 2 | <1 | 64 | <4 | >4 | blaCTX-M-27 | not determined |
| 7 |
| 16 | >32 | >2 | >2 | >64 | <4 | >4 |
| not transferred |
| 7′ |
| >16 | >32 | >2 | >2 | 64 | <4 | >4 |
| not transferred |
| 8 |
| <2 | >32 | 2 | <1 | <16 | <4 | <0.5 | not detected | not determined |
| 9 |
| <2 | >32 | 2 | <1 | <16 | <4 | <0.5 | not detected | not determined |
CFPM = cefepime, CMZ = cefmetazole, IPM = imipenem, MEPM = meropenem, P/T = piperacillin/tazobactam, AMK = amikacin, LVFX = levofloxacin.
Figure 1Pulsed-field gel electrophoresis (PFGE) patterns of XbaI-digested DNA from 10 carbapenem-resistant. Enterobacteriaceae isolates. Ten Enterobacteriaceae (CRE) strains had eight PFGE patterns (A–H) with no predominant pattern. The PFGE patterns of two E. cloacae strains detected from Patients 2 and 7 were identical (F1) and those of two E. cloacae strains detected from Patients 7 and 7′ were closely related (F1 and F2, respectively).
Figure 2Results of the microtiter biofilm assay. The mean OD595 values of 10 CRE strains were all more than 2.0, and biofilm formations were confirmed.
Figure 3Results of the drip-flow biofilm assay. A confocal microscopic analysis indicated the upstream biofilm in the chamber had a thickness of approximately 20–22 μm with a smooth surface. The biofilm thickness in the downstream portion of the chamber, however, was approximately 30–35 μm.